Insmed reports inducement grants under Nasdaq listing rule

• Insmed (NASDAQ:INSM) has announced the granting of inducement awards to six new employees which will receive options on Dec. 1, 2021 to purchase an aggregate 43,610 shares of common stock at an exercise price of $26.69/share.
• The options have a 10-year term and a 4-year vesting schedule, with 25% of the shares subject to the option vesting on the first anniversary of the relevant grant date and 12.5% of the shares.
• In accordance with NASDAQ Listing Rule, the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Co.